
GC36792
Odiparcil
Also known as 4-methyl-7-[(2R,3R,4S,5S)-3,4,5-trihydroxythian-2-yl]oxychromen-2-one
Odiparcil (SB-424323) is an orally active beta-d-thioxyloside analog with antithrombotic activity associated with a reduced risk of adverse bleeding events
ChemicalCAS137215-12-4MW324.35FormulaC15H16O6S
- CAS number
- 137215-12-4
- Molecular weight
- 324.35
- Formula
- C15H16O6S
- Solubility
- DMSO : 100 mg/mL (308·31 mM; Need ultrasonic)
- InChIKey
- JRHNIQQUVJOPQC-AQNFWKISSA-N
- Catalogue number
- GC36792
- Brand
- GLPBIO
Computed properties PubChem CID 216385 · XLogP 0.1 · TPSA 122 Ų · H-bond donors 3
- XLogP
- 0.1
- TPSA
- 122 Ų
- H-bond donors
- 3
- H-bond acceptors
- 7
- Rotatable bonds
- 2
- Heavy atoms
- 22
SMILES CC1=CC(=O)OC2=C1C=CC(=C2)O[C@H]3[C@@H]([C@H]([C@@H](CS3)O)O)O
Computed descriptors from PubChem (CID 216385), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il